The administration wants to slash National Institutes of Health funding for equipment, security, energy bills and other ...

We truly risk losing our international standing as a leader in bettering public health,' Texas Biomed's CEO said.

San Antonio's infectious disease hub is optimistic despite uncertainty about federal scientific research grants under President Donald Trump.

A live-attenuated tuberculosis (TB) vaccine candidate in development elicits a much more balanced and effective immune response compared to the existing vaccine used across much of the world, ...

Approved 30-1, legislation creating a dementia research institute funded with $3 billion in state money next goes to the Texas House.

Dr. Larry Schlesinger, president/CEO of Texas Biomedical Research Institute, said a planned NIH cutback “will have a longstanding detrimental effect” on human health and America’s role as ...

A live-attenuated tuberculosis (TB) vaccine candidate in development at Texas Biomedical Research Institute (Texas Biomed) elicits a much more balanced and effective immune response compared to ...